Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Journal of Neuromuscular Diseases
|
June 21, 2021
Revertant Phenomenon in DMD and LGMD2I and Its Therapeutic Implications: A Review of Study Under Mentorship of Terrence Partridge
Qi Long Lu
Methods in Molecular Biology (Clifton, N.J.)
|
March 29, 2012
Systemic delivery of antisense oligomer in animal models and its implications for treating DMD
Qi Long Lu, Bo Wu
Methods in Molecular Biology (Clifton, N.J.)
|
July 28, 2025
In Vivo Evaluation of Dystrophin Exon Skipping in mdx Mice
Bo Wu, Qi Long Lu
Discovery Medicine
|
August 14, 2010
Antisense therapy corrects nonsense mutation by exon skipping
Qi Long Lu, Terence A Partridge
Molecular Therapy. Methods & Clinical Development
|
November 13, 2018
Dose-Dependent Effects of FKRP Gene-Replacement Therapy on Functional Rescue and Longevity in Dystrophic Mice
Charles Harvey Vannoy, Victoria Leroy, Qi Long Lu
Plos One
|
January 11, 2018
Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice
Anthony Blaeser, Hiroyuki Awano, Pei Lu, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 2, 2018
In Vivo Evaluation of Dystrophin Exon Skipping in mdx Mice
Bo Wu, Mingxing Wang, Sapana Shah, et al.
Plos One
|
October 7, 2016
Progressive Dystrophic Pathology in Diaphragm and Impairment of Cardiac Function in FKRP P448L Mutant Mice
Anthony Blaeser, Hiroyuki Awano, Bo Wu, et al.
Nature Communications
|
August 29, 2018
Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice
Marcela P Cataldi, Peijuan Lu, Anthony Blaeser, et al.
Scientific Reports
|
July 13, 2019
Metabolomics Analysis of Skeletal Muscles from FKRP-Deficient Mice Indicates Improvement After Gene Replacement Therapy
Charles Harvey Vannoy, Victoria Leroy, Katarzyna Broniowska, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Journal of Neuromuscular Diseases
|
June 21, 2021
Revertant Phenomenon in DMD and LGMD2I and Its Therapeutic Implications: A Review of Study Under Mentorship of Terrence Partridge
Qi Long Lu
Methods in Molecular Biology (Clifton, N.J.)
|
March 29, 2012
Systemic delivery of antisense oligomer in animal models and its implications for treating DMD
Qi Long Lu, Bo Wu
Methods in Molecular Biology (Clifton, N.J.)
|
July 28, 2025
In Vivo Evaluation of Dystrophin Exon Skipping in mdx Mice
Bo Wu, Qi Long Lu
Discovery Medicine
|
August 14, 2010
Antisense therapy corrects nonsense mutation by exon skipping
Qi Long Lu, Terence A Partridge
Molecular Therapy. Methods & Clinical Development
|
November 13, 2018
Dose-Dependent Effects of FKRP Gene-Replacement Therapy on Functional Rescue and Longevity in Dystrophic Mice
Charles Harvey Vannoy, Victoria Leroy, Qi Long Lu
Plos One
|
January 11, 2018
Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice
Anthony Blaeser, Hiroyuki Awano, Pei Lu, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
September 2, 2018
In Vivo Evaluation of Dystrophin Exon Skipping in mdx Mice
Bo Wu, Mingxing Wang, Sapana Shah, et al.
Plos One
|
October 7, 2016
Progressive Dystrophic Pathology in Diaphragm and Impairment of Cardiac Function in FKRP P448L Mutant Mice
Anthony Blaeser, Hiroyuki Awano, Bo Wu, et al.
Nature Communications
|
August 29, 2018
Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice
Marcela P Cataldi, Peijuan Lu, Anthony Blaeser, et al.
Scientific Reports
|
July 13, 2019
Metabolomics Analysis of Skeletal Muscles from FKRP-Deficient Mice Indicates Improvement After Gene Replacement Therapy
Charles Harvey Vannoy, Victoria Leroy, Katarzyna Broniowska, et al.
Page
of 5